![Weight-loss drug could reduce heart attack risk](https://eshaspain.org/wp-content/uploads/2024/05/christine-sandu-jwWtZrm67VI-unsplash-600x400.jpg)
Weight-loss drug could reduce heart attack risk
A study presented at the European Congress of Obesity (ECO) has unveiled promising news for millions struggling with cardiovascular health. Researchers at University College London investigated the effects of semaglutide, a medication already used for weight loss under brand names Wegovy and Ozempic. The groundbreaking aspect? Participants taking semaglutide experienced a 20% lower risk of